Dorsal Root Ganglion Stimulation for the Treatment of Arthritic Knee Pain

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-01

Study Completion Date

2026-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dorsal root ganglion stimulation (DRG-S) may be able to treat mechanical pain caused by tissue injury or damage such as trauma or arthritis in addition to pain caused by nerve dysfunction or injury. The purpose of this study is to determine if dorsal root ganglion stimulation (DRG-S) can effectively treat arthritic pain of the knee.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Use of Bone Growth Stimulators for Osteoarthritis of the Knee.

NCT03476382

Osteo Arthritis Knee

COMPLETED NA

Treating Chronic Knee Pain with Noninvasive Peripheral Nerve Stimulation Using Novel Interferential RadioFrequencies

NCT06626854

Chronic Knee Pain Chronic Knee Osteoarthritis Post Surgical Neuropathic Pain

NOT_YET_RECRUITING EARLY_PHASE1

Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis

NCT06257537

Osteo Arthritis Knee Arthritis

RECRUITING PHASE2

Effectiveness of Resistive Capacitive Diathermy in Patients Affected by Knee Osteoarthritis

NCT01800955

Knee Osteoarthritis

COMPLETED NA

Genicular Radiofrequency Ablation Efficacy in Achieving Total Knee Pain Reduction Trial

NCT02947321

Knee Arthroplasty, Total Osteoarthritis Radiologic Tibiofemoral Osteoarthritis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Dorsal root ganglion stimulation (DRG-S) is a novel form of neuromodulation used to treat chronic neuropathic pain of the groin and lower extremities related to complex regional pain syndrome type I or II (causalgia). DRG-S has shown promise in treating traditionally mixed neuropathic and mechanical pain syndromes such as axial low back pain, suggesting DRG-S may be able to treat mechanical pain in addition to neuropathic pain. Additionally, in a rodent model of osteoarthritis of the knee, DRG-S alleviated pain related behavior in rats.

This open label feasibility study seeks to evaluate if dorsal root ganglion stimulation with Abbott's Proclaim Dorsal Root Ganglion Neurostimulator System can effectively treat osteoarthritis of the knee. Patients with either osteoarthritis of the non-operated knee or osteoarthritis of the surgically repaired knee will be trialed for one week with dorsal root ganglion stimulation to determine if they positively respond with 50% or greater pain relief. For those patients that have a successful trial, they will be implanted with a permanent stimulation device system and followed for one year post implant to measure knee pain, function and disability, and other related outcomes with sustained DRG-S therapy.

Patients will be seen and evaluated prior to DRG-S trial, and for those that receive permanent implants, re-evaluated at 1, 3, 6, 9 and 12 months after implant.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knee Osteoarthritis Knee Pain Chronic Knee Arthritis Knee Arthropathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Subjects will undergo one week DRG-S trial, and for those that respond as defined by 50% or greater pain relief, proceed to DRG-S permanent device system implant

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Non-operated Knee Osteoarthritis

DRG-S for knee osteoarthritis patients with no history of knee surgery

Group Type EXPERIMENTAL

Dorsal Root Ganglion Stimulation

Intervention Type DEVICE

Stimulation at L2, L3, L4 and S1 spinal levels

Surgically Repaired Knee Osteoarthritis

DRG-S for knee osteoarthritis patients with history of surgical repair of the knee

Group Type EXPERIMENTAL

Dorsal Root Ganglion Stimulation

Intervention Type DEVICE

Stimulation at L2, L3, L4 and S1 spinal levels

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dorsal Root Ganglion Stimulation

Stimulation at L2, L3, L4 and S1 spinal levels

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \>= 21 years old
* Able to provide informed consent
* Primary complaint of chronic knee pain for at least 1 year that interferes with functional activities
* Current pain score on visual analog scale (VAS) intensity ≥60 mm
* One of two groups: 1) Non-operated knee pain patients who want to pursue alternative therapies and delay surgery or are not candidates for knee arthroplasty based on age, frailty, non-operable condition, or poor outcome with other side arthroplasty, or 2) Post traumatic knee pain patients with history of surgical repair (such as meniscal or ligament repair).
* Radiologic confirmation (x-ray/MRI/CT) of Kellgren-Lawrence OA grade of 2 (mild) or 3 (moderate) or 4 (severe) noted within 6 months for the index knee
* Continued pain in the target knee despite at least 3 months of conservative treatments with documented failure of physical therapy and standard conservative therapy, including trials of at least two different classes of analgesic medication
* Failure of one or more prior interventional pain procedures such intraarticular corticosteroid or hyaluronidase knee injections, cooled radiofrequency ablation therapy, or regenerative medicine or prior surgery of the knee

Exclusion Criteria

* Non-English speaking
* Douleur neuropathique 4 (DN4) score ≥4
* Receiving opioid analgesic medication at a dose of ≥90 mg oral morphine equivalents
* Workers' compensation or no-fault insurance
* Signs or symptoms of active infection in the index knee joint
* Pregnancy
* BMI \>45
* Presence of any contraindication for DRG stimulation, including neurological, medical, psychiatric, or social conditions.
* Widespread pain conditions like fibromyalgia
* Autoimmune/Inflammatory arthritic conditions such as Rheumatoid and psoriatic arthritis and other allied disorders (sjogren, felty, inflammatory bowl disease etc)
* Collagen diseases (systemic lupus erythematosus, Scleroderma, etc)
* Infectious arthritis
* Evidence of prespecified joint safety conditions (eg, rapidly progressive OA, subchondral insufficiency fracture, osteonecrosis, pathologic fracture) in the index knee on screening radiographs
* Scheduled for or anticipating any surgery during the trial period

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No